ppharmПедиатрическая фармакологияPediatric pharmacology1727-57762500-3089Издательство «ПедиатрЪ»10.15690/pf.v10i4.755ppharm-195Research ArticleНЕОТЛОЖНЫЕ СОСТОЯНИЯ У ДЕТЕЙEMERGENCY CONDITIONS IN CHILDRENГЕПАТОБИЛИАРНЫЕ ОСЛОЖНЕНИЯ ПАРЕНТЕРАЛЬНОГО ПИТАНИЯ У ДЕТЕЙHEPATOBILIARY COMPLICATIONS OF PARENTERAL NUTRITION IN CHILDRENТепаевР. Ф.TepaevR. F.

доктор медицинских наук, главный научный сотрудник отделения анестезиологии-реанимации Научного центра здоровья детей РАМН, профессор кафедры педиатрии с курсом детской ревматологии Первого Московского государственного медицинского университета им. И.М. Сеченова

PhD, chief research scientist at the anesthesiology-resuscitation department of the Scientific Center of Children’s Health, Professor at the pediatrics department with a course of pediatric rheumatology at the First Sechenov Moscow State Medical University

rtepaev@inbox.ruКирьяноваА. Н.KiryanovaA. N.ИльичёваЕ. И.IlyichevaE. I.Научный центр здоровья детей РАМН, Москва, Российская Федерация Первый Московский государственный медицинский университет им. И.М. Сеченова, Российская ФедерацияРоссияScientific Center of Children’s Health, Moscow, Russian Federation First Sechenov Moscow State Medical University, Russian FederationRussian FederationНаучный центр здоровья детей РАМН, Москва, Российская ФедерацияРоссияScientific Center of Children’s Health, Moscow, Russian FederationRussian Federation201314082013104Педиатрическая фармакология5359Copyright © Тепаев Р.Ф., Кирьянова А.Н., Ильичёва Е.И., 20132013Тепаев Р.Ф., Кирьянова А.Н., Ильичёва Е.И.Tepaev R.F., Kiryanova A.N., Ilyicheva E.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.pedpharma.ru/jour/article/view/195

Parenteral nutrition allows adequately providing children’s bodies with amino acids, carbohydrates, fats and energy required to maintain the baseline energy level and correct the preceding nutritive deficiency. Long-term parenteral nutrition is associated with hepatobiliary complications of varying severity – from transitory complications to lethal ones, caused by cholestasis. The article presents modern data on diagnostics, prevention and treatment of hepatobiliary complications of parenteral nutrition in children.

детихолестаззаболевание печениассоциированное с парентеральным питаниемchildrencholestasisliver diseaseassociated with parenteral nutritionReferencesLauriti G., Zani A., Aufieri R., Cananzi M. et al. Incidence, prevention, and treatment of parenteral nutrition-associated cholestasis and intestinal failure-associated liver disease in infants and children: a systematic review. JPEN J Parenter Enteral Nutr. July 26, 2013.Lauriti G., Zani A., Aufieri R., Cananzi M. et al. Incidence, prevention, and treatment of parenteral nutrition-associated cholestasis and intestinal failure-associated liver disease in infants and children: a systematic review. JPEN J Parenter Enteral Nutr. July 26, 2013.Liver structure cartoon. Retrieved September 1, 2013. URL: http://php.med.unsw.edu.au/embryology/index.php?title=Liver structure cartoon. Retrieved September 1, 2013. URL: http://php.med.unsw.edu.au/embryology/index.php?title=Beath S., Pironi L., Gabe S., Horslen S., Sudan D., Maze riegos G., Steiger E., Goulet O., Fryer J. Collaborative strategies to reduce mortality and morbidity in patients with chronic intestinal failure including those who are referred for small bowel transplantation. Transplantation. 2008; 85: 1378–1384.Beath S., Pironi L., Gabe S., Horslen S., Sudan D., Maze riegos G., Steiger E., Goulet O., Fryer J. Collaborative strategies to reduce mortality and morbidity in patients with chronic intestinal failure including those who are referred for small bowel transplantation. Transplantation. 2008; 85: 1378–1384.Lee S. M., Namgung R., Park M. S., Eun H. S., Kim N. H., Park K. I., Lee C. Parenteral nutrition associated cholestasis is earlier, more prolonged and severe in small for gestational age compared with appropriate for gestational age very low birth weight infants. Yonsei Med J. 2013 Jul 1.Lee S. M., Namgung R., Park M. S., Eun H. S., Kim N. H., Park K. I., Lee C. Parenteral nutrition associated cholestasis is earlier, more prolonged and severe in small for gestational age compared with appropriate for gestational age very low birth weight infants. Yonsei Med J. 2013 Jul 1.Li Y. H., Wang X. L. Risk factors for parenteral nutrition-associated cholestasis in preterm infants. Zhongguo Dang Dai Er Ke Za Zhi. 2013 Apr.Li Y. H., Wang X. L. Risk factors for parenteral nutrition-associated cholestasis in preterm infants. Zhongguo Dang Dai Er Ke Za Zhi. 2013 Apr.Koletzko B., Goulet O., Hunt J., Krohn K., Shamir R. for the Parenteral Nutrition Guidelines Working Group. Guidelines on Paediatric Nutrition of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), European Society for Clinical Nutrition and Metabolism (ESPEN) and the European Society for Paediatric Research (ESPR). J Pediatr Gastroenterol Nutr. 2005; 41, Suppl. 2.Koletzko B., Goulet O., Hunt J., Krohn K., Shamir R. for the Parenteral Nutrition Guidelines Working Group. Guidelines on Paediatric Nutrition of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), European Society for Clinical Nutrition and Metabolism (ESPEN) and the European Society for Paediatric Research (ESPR). J Pediatr Gastroenterol Nutr. 2005; 41, Suppl. 2.Cavicchi et al. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med. 2000; 132: 525–532.Cavicchi et al. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med. 2000; 132: 525–532.Llop J. M. et al. Phytosterolemia in parenteral nutrition patients: implications for liver disease development. Nutrition. 2008 Nov-Dec; 24 (11–12): 1145–52.Llop J. M. et al. Phytosterolemia in parenteral nutrition patients: implications for liver disease development. Nutrition. 2008 Nov-Dec; 24 (11–12): 1145–52.URL: http://www.md.ucl.ac.be/pedihepa/TPNhepato.htmURL: http://www.md.ucl.ac.be/pedihepa/TPNhepato.htmШирокова Е. Н. Холестаз: вопросы патогенеза, диагностики и лечения. Кафедра пропедевтики внутренних болезней ГОУ ВПО ММА им. И. М. Сеченова. Журнал Consilium medicum. 2007; 9 (7).Широкова Е. Н. Холестаз: вопросы патогенеза, диагностики и лечения. Кафедра пропедевтики внутренних болезней ГОУ ВПО ММА им. И. М. Сеченова. Журнал Consilium medicum. 2007; 9 (7).Голованова Е. В. Диагностика и лечение внутрипеченочного холестаза при хронических заболеваниях печени. Автореф. дисс. … докт. мед. наук. Москва. 2008.Голованова Е. В. Диагностика и лечение внутрипеченочного холестаза при хронических заболеваниях печени. Автореф. дисс. … докт. мед. наук. Москва. 2008.Nandivada P., Cowan E., Carlson S. J., Chang M., Gura K. M., Puder M. Mechanisms for the effects of fish oil lipid emulsions in the management of parenteral nutrition-associated liver disease. 2013. URL: http://www.ncbi.nlm.nih.gov/pubmed/23602846Nandivada P., Cowan E., Carlson S. J., Chang M., Gura K. M., Puder M. Mechanisms for the effects of fish oil lipid emulsions in the management of parenteral nutrition-associated liver disease. 2013. URL: http://www.ncbi.nlm.nih.gov/pubmed/23602846Rafeeq М. et al. A sudden and marked reduction in PN cholestasis on changing from a conventional intravenous lipid source to SMOF lipid. J Pediatr Gastroenterol Nutr. 2009; 48 (Suppl. 3): е140.Rafeeq М. et al. A sudden and marked reduction in PN cholestasis on changing from a conventional intravenous lipid source to SMOF lipid. J Pediatr Gastroenterol Nutr. 2009; 48 (Suppl. 3): е140.Tomsits E. et al. Efficacy of a lipid emulsion containing a mixture of soybean oil, MCT, olive oil and fish oil: A randomized, doubleblind clinicaltrial in premature infants requiring parenteral nutrition. J Pediatr Gastroenterol Nutr. 2009 (under review).Tomsits E. et al. Efficacy of a lipid emulsion containing a mixture of soybean oil, MCT, olive oil and fish oil: A randomized, doubleblind clinicaltrial in premature infants requiring parenteral nutrition. J Pediatr Gastroenterol Nutr. 2009 (under review).Rayyan M. et al. A randomised, double-blind study evaluating the safety, tolerability and efficacy of SMOF 20% comparedRayyan M. et al. A randomised, double-blind study evaluating the safety, tolerability and efficacy of SMOF 20% comparedto Intralipid 20% in premature infants. J Pediatr Gastroenterol Nutr. 2007; 44: e314.to Intralipid 20% in premature infants. J Pediatr Gastroenterol Nutr. 2007; 44: e314.Goulet O. et al. Long terrm efficacy and safety of a new olive oilbased intravenous fat emulsion in pediatric patients: a double-blind randomized study. Am J Clin Nutr. 1999 Sep; 70: 338–45.Goulet O. et al. Long terrm efficacy and safety of a new olive oilbased intravenous fat emulsion in pediatric patients: a double-blind randomized study. Am J Clin Nutr. 1999 Sep; 70: 338–45.De Marco G. et al. Early treatment with ursodeoxycholic acid for cholestasis in children on parenteral nutrition because of primary intestinal failure. Alimentary Pharmacology & Therapeutics. July 2006; 24 (2): 387–394.De Marco G. et al. Early treatment with ursodeoxycholic acid for cholestasis in children on parenteral nutrition because of primary intestinal failure. Alimentary Pharmacology & Therapeutics. July 2006; 24 (2): 387–394.Beath S. V., Woodward J. M. Intestinal failure associated liver disease. In Langnas A. N., Goulet O., Quigley E. M. M., Tappenden K. A. (eds): Intestinal failure diagnosis, management and transplantation. Oxford, Blackwell Publishing. 2008. Р. 191–200.Beath S. V., Woodward J. M. Intestinal failure associated liver disease. In Langnas A. N., Goulet O., Quigley E. M. M., Tappenden K. A. (eds): Intestinal failure diagnosis, management and transplantation. Oxford, Blackwell Publishing. 2008. Р. 191–200.

The authors declare that there are no conflicts of interest present.